FDA Approves Dexcom's Stelo Glucose Monitor for OTC Use
Tuesday, 5 March 2024, 22:29
Important FDA Approval for Dexcom's Stelo Glucose Monitor
The FDA has given the green light for Dexcom's continuous glucose monitoring device, Stelo, to be available over-the-counter for individuals aged 18 years and above.
Key Points:
- Accessibility: People can now purchase Stelo without needing a prescription, improving access to essential diabetes management tools.
- Health Empowerment: Users can monitor their glucose levels conveniently and proactively, leading to better health outcomes.
- Innovation: Dexcom's Stelo represents a leap forward in glucose monitoring technology for improved quality of life.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.